alexa Investigation the Cognitive Impairment in Diabetes Mellitus Type 2 with Moca Test | OMICS International
ISSN: 2378-5756
Journal of Psychiatry
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Investigation the Cognitive Impairment in Diabetes Mellitus Type 2 with Moca Test

Tuba Özcan1*and Esra Yancar Demir2


1Ordu University, School of Medicine, Department of Neurology, Ordu/ Turkey

2Ordu University, School of Medicine, Department of Psychiatry, Ordu/ Turkey

*Corresponding Author:
Tuba Özcan
Ordu Üniversitesi, Tıp Fakültesi
Nöroloji AD, Ordu/Turkey
Tel: 90 533 4796529
E-mail: [email protected]

Received Date: July 1, 2014; Accepted Date: September 26, 2014; Published Date: October 3, 2014

Citation: Özcan T, Demir EY (2014) Investigation the Cognitive Impairment in Diabetes Mellitus Type 2 with Moca Test. J Psychiatry 17:1000166. doi: 10.4172/Psychiatry.1000166

Copyright: © 2014, Özcan and Demir. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Psychiatry


Diabetes Mellitus; cognitive impairment; MoCA test


Type 2 diabetes mellitus (DM) is one of the most common major diseases in older adults, and its prevalence increases with age [1,2]. Patients with DM are subjected to micro angiopathic complications as neuropathy, retinopathy, nephropathy and macro angiopathic atherosclerosis as stroke and ischemic heart disease. DM not only causes somatic complications but also may lead to cognitive dysfunction [3-8]. Several hypotheses have been suggested for a relationship between DM and cognitive impairment (CI). One of them is DM has an indirect effect on cognition via vascular disease [9]. It was reported that elderly DM patients have impaired cognition in comparison to age- matched controls [10,11]. Although cognitive dysfunction has been reported in patients with DM, there is not any specific domains of cognition that may be related by DM [3,12,13].

The aim of this investigation is to reveal the relationship between diabetes mellitus type 2 and cognitive impairment.

Material and Methods

This retrospective study was performed in Ordu University. After the study protocol was approved by the local ethical committee, over a 6-month period, a total of 15 DM (12 male and 3 female) and, 15 non- DM (12 male and 3 female) subjects were included the study. Each DM patient was matched when possible with a non- DM control subject, of the same gender and whose age was within 2 years of that of the patient. None of the control subject had a history of DM and had not been prescribed oral hypoglycaemic agents or insulin. All patients were aged 60 years or more. Information collected from other hospital records and medical notes.

The Montreal Cognitive Assessment (MoCA) is a screening instrument for CI, but MoCA has not been validated in patients with DM. The MoCA consists of 7 subscores: visuospatial/executive (5 points); naming (3 points); memory (5 points for delayed recall); attention (6 points); language (3 points); abstraction (2 points); and orientation (6 points) and upper score limit is 30. One point is added if the subject has 12 years of education. The cut-off value is determined as 21 [14,15].

Statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS), Version 20. Descriptive statistics were used to summarize all measurements. All continuous data mean ± standard deviation. The Mann-Whitney U test and chi-square test was used for statistical comparisons. The level of statistical significance was set as p<0.05.


Mean age of the study subjects was 69.9 ± 7.43years and 6 (20%) of the study subjects were females. Statistical analysis did not show significant difference between education level of two groups (p: 0.824). The frequency of CI was 83.3% (25/30) in the whole group and 73.3% (11/15) in patients with DM, whereas it was 93.3% (14/15) in non- DM group. The mean scores were 15.53 ± 6.18 and 15.40 ± 3.99, respectively (p: 0.945). Characteristics of diabetic and non-diabetic group are shown in Table 1. There was no significant difference between diabetic and non-diabetic groups in terms of MoCA domains Table 2.




In the present study, we investigated factors associated with CI in elderly DM subjects using MoCA. Compared with an age- and gender-matched group of non-diabetic control subjects, this study demonstrated that no differences of frequency for CI in an elderly group of patients with DM.

In previous studies, controversial results have been stated for the DM as a risk for CI. Although some of the studies have found a relationship between DM and CI, others have reported no relationship [4-8,16]. Katzman et al. found an association between DM and dementia [17]. Contrary, in a cross-sectional study conducted by Croxson et al. did not find a significant difference [18]. In another study, authors concluded that, borderline diabetes increases risks of dementia [19]. In our study, regardless of a small number of participants and a different method and scale in determination of CI, we did not found a different frequency of CI in diabetic group.

Prevalence of CI in DM ranging from 20% to 38% [20,21,22]. In a population-based study, CI in patients with DM was reported as 28% [20]. CI frequency in our study, in both DM (73.3%) and non-DM groups (93.3%) is much higher than the literature and it makes us to think that MoCA test is not appropriate for our population or we have made mistakes in patient selection. It should be related to lower educational state of our patients and the absence of the MoCA test form for untrained people. Also, cause of retrospective design of the study, none of the control subject’s brain imaging was evaluated. So, we cannot say that our control group was entirely healthy people. On the other hand, other etiological factors might be interacted to our results. We did not, therefore, examine all possible factors which may have effect on CI. We also did not specifically examine the unrecognized depression or DM and medication. Moreover, we did not question the past history of intellectual ability, which may have implications for evaluating the cognition.

Main limitation of our study is small sample size. The other limitations of our study are not excluding the metabolic and the structural conditions were not excluded. Maybe, we should have investigated the routine blood tests and neuroimaging to find the other causes of CI.

In the present study we evaluated the effect of DM on CI. We compared frequency of CI in diabetic and non-diabetic group, matched in age, sex and educational state. According to our findings, CI was similar in both groups and frequency was not different between groups. Furhter studies with longitudinal designs are needed to identify the relationship between DM and CI.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 12234
  • [From(publication date):
    November-2014 - Jun 24, 2018]
  • Breakdown by view type
  • HTML page views : 8419
  • PDF downloads : 3815

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7